LJN 452
Tropifexor
CAS: 1383816-29-2
Molecular Formula: C29H25F4N3O5S
LJN 452 - Names and Identifiers
LJN 452 - Physico-chemical Properties
| Molecular Formula | C29H25F4N3O5S |
| Molar Mass | 603.58 |
| Density | 1.55±0.1 g/cm3(Predicted) |
| Boling Point | 700.0±65.0 °C(Predicted) |
| pKa | 3.84±0.10(Predicted) |
| Storage Condition | -20℃ |
| In vitro study | LJN-452 in vitro pharmacological studies is a human FXR agonist, the selectivity of human FXR is more than 30,000 times higher than other nuclear receptors. In primary human hepatocytes, LJN-452 increased the expression levels of BSEP and SHP. |
| In vivo study | Pharmacokinetic studies in rats showed that Tropifexor had a low clearance rate (CL = 9 ml/min/kg) and a long terminal Half-Life (T1/2=3.7 h). tropifexor was formulated as an aqueous microemulsion formulation with an oral bioavailability of 20% in rats. In mice, administered intravenously, Tropifexor has low clearance, small volume of distribution, and a half-life of 2.6 hours. In dogs, after intravenous injection, Tropifexor has a half-life of 7.4 hours and a volume of distribution of 0.46 L/kg. In single and multiple dose experiments, LJN-452 were able to target FXR in intestinal epithelial cells, resulting in a concentration-dependent increase in FGF-19 levels. In ANIT-induced liver injury model, Tropifexor can improve liver transaminases and fibrosis. |
LJN 452 - Preparation solution concentration reference
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 1.657 ml | 8.284 ml | 16.568 ml |
| 5 mM | 0.331 ml | 1.657 ml | 3.314 ml |
| 10 mM | 0.166 ml | 0.828 ml | 1.657 ml |
| 5 mM | 0.033 ml | 0.166 ml | 0.331 ml |
Last Update：2024-01-02 23:10:35
LJN 452 - Introduction
Tropifexor, full name Cyclic Pyrroloimidazole DNA-alkylating agent 1549, is a DNA alkylating agent. It has the following properties:
1. Chemical properties: Tropifexor is an organic compound with cyclic pyrrole and imidazole groups in its chemical structure. It has a strong affinity for DNA and can be covalently bound to DNA.
2. Use: Tropifexor is often used as an anticancer drug in the field of biomedicine. It can alkylate the DNA of cancer cells by covalent binding with DNA, thus blocking the process of DNA replication and transcription, and achieving the purpose of inhibiting the growth and division of cancer cells.
3. Preparation method: Tropifexor preparation method is more complex, generally involving multi-step organic synthesis reaction. The specific system cannot be made public for reasons such as patent protection.
4. Safety Information: because Tropifexor is a powerful DNA alkylating agent, it has high toxicity. When using or studying Tropifexor, strictly follow laboratory safety regulations and operating procedures, and wear appropriate protective equipment. Avoid skin contact, inhalation or swallowing. If accidental contact occurs, rinse immediately with plenty of water and seek medical attention. For specific toxicity, Hazard and protection requirements, please refer to the relevant chemical safety data form (SDS) or obtain it from the supplier.
1. Chemical properties: Tropifexor is an organic compound with cyclic pyrrole and imidazole groups in its chemical structure. It has a strong affinity for DNA and can be covalently bound to DNA.
2. Use: Tropifexor is often used as an anticancer drug in the field of biomedicine. It can alkylate the DNA of cancer cells by covalent binding with DNA, thus blocking the process of DNA replication and transcription, and achieving the purpose of inhibiting the growth and division of cancer cells.
3. Preparation method: Tropifexor preparation method is more complex, generally involving multi-step organic synthesis reaction. The specific system cannot be made public for reasons such as patent protection.
4. Safety Information: because Tropifexor is a powerful DNA alkylating agent, it has high toxicity. When using or studying Tropifexor, strictly follow laboratory safety regulations and operating procedures, and wear appropriate protective equipment. Avoid skin contact, inhalation or swallowing. If accidental contact occurs, rinse immediately with plenty of water and seek medical attention. For specific toxicity, Hazard and protection requirements, please refer to the relevant chemical safety data form (SDS) or obtain it from the supplier.
Last Update：2024-04-09 21:04:16
Supplier List
Spot supply
Product Name: LJN452 Visit Supplier Webpage Request for quotationCAS: 1383816-29-2
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: LJN452 Visit Supplier Webpage Request for quotationCAS: 1383816-29-2
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 18621343501
WhatsApp: +86-18621343501
Spot supply
Product Name: Tropifexor (LJN452) Visit Supplier Webpage Request for quotationCAS: 1383816-29-2
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328
WhatsApp: +86-18821248368
Spot supply
Product Name: Tropifexor Visit Supplier Webpage Request for quotationCAS: 1383816-29-2
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Spot supply
Product Name: LJN452 Visit Supplier Webpage Request for quotationCAS: 1383816-29-2
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: LJN452 Visit Supplier Webpage Request for quotationCAS: 1383816-29-2
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 18621343501
WhatsApp: +86-18621343501
Spot supply
Product Name: Tropifexor (LJN452) Visit Supplier Webpage Request for quotationCAS: 1383816-29-2
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328
WhatsApp: +86-18821248368
Spot supply
Product Name: Tropifexor Visit Supplier Webpage Request for quotationCAS: 1383816-29-2
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
View History
LJN 452
CHEMBRDG-BB 3017966
双胍三辛烷基苯磺酸盐溶液, 1000PPM
2-(2-[(4-METHYLBENZYL)SULFANYL]PHENYL)-5-PHENYL-1,3,4-OXADIAZOLE
金刚烷-1,3-二胺
3,5,7-Triaza-1-azoniatricyclo[3.3.1.13,7]decane, 1-(2-methoxy-2-oxoethyl)-, chloride (1:1)
CHEMBRDG-BB 3017966
双胍三辛烷基苯磺酸盐溶液, 1000PPM
2-(2-[(4-METHYLBENZYL)SULFANYL]PHENYL)-5-PHENYL-1,3,4-OXADIAZOLE
金刚烷-1,3-二胺
3,5,7-Triaza-1-azoniatricyclo[3.3.1.13,7]decane, 1-(2-methoxy-2-oxoethyl)-, chloride (1:1)